TABLE 1.
Patient characteristics.
| Recipient characteristics | Pre-HT | Post-HT | ||||
|---|---|---|---|---|---|---|
| N = 28 | Missing | N = 28 | Missing | |||
| Age (years) | 50 | (45; 60) | 0 | 52 | (47; 62) | 0 |
| Female, N (%) | 6 | (21) | 0 | 6 | (21) | 0 |
| BMI (kg/m2) | 27 | (24; 28) | 1 | 26 | (23; 30) | 0 |
| Serum creatinine (µmol/L) | 106 | (88; 121) | 0 | 114 | (97; 142) | 0 |
| Creatinine based eGFR | 65 | (57; 82) | 0 | 54 | (45; 75) | 0 |
| Iohexol-GFR (ml/min/1.73 m2) | 56 | (45; 69) | 13 | 53 | (46; 78) | 2 |
| Daily administration of systemic CS, N (%) | 1 | (4) | 0 | 27 | (96) | 0 |
| Primary indication for HT | 0 | |||||
| Dilated cardiomyopathy | 19 | (68) | ||||
| Hypertrophic cardiomyopathy | 2 | (7) | ||||
| Ischemic cardiomyopathy | 2 | (7) | ||||
| Other | 5 | (18) | ||||
| BMD (g/m2) | ||||||
| Lumbar spine | 1.135 | (1.028; 1.272) | 1.113 | (0.944; 1.188) | 3 | |
| Femoral neck | 1.001 | (0.946; 1.063) | 0.904 | (0.818; 0.966) | 3 | |
| T score (SD) | ||||||
| Lumbar spine | −0.7 | (−1.6; 0.4) | −1.0 | (−2.3; −0.2) | 2 | |
| Femoral neck | −0.7 | (−1.0; −0.1) | −1.4 | (−1.9; −0.9) | 2 | |
Values for continuous variables are expressed as median (IQR), whereas categorical values are expressed as number (%). BMD, bone mineral density; BMI, body mass index; CS, corticosteroids; HT, heart transplantation; (e)GFR, (estimated) glomerular filtration rate; IQR, interquartile range; SD, standard deviation.